Radico Khaitan Q1: consolidated PAT jumps 76% YoY to ₹230 Cr on sharp margin expansion
PAT +75.93% YoY · revenue +10.43% · margins expanding · beat vs street
₹5,867.69 Cr
+10.43% YoY
₹229.6 Cr
+75.93% YoY
3.91%
+1.5pp YoY
₹17.15
Radico Khaitan opened FY27 with a profit-led beat. Consolidated net profit rose ~76% YoY to ₹229.6 Cr (₹230 Cr) on gross revenue of ₹5,867.7 Cr, up 10.4% YoY; on a net-of-excise basis sales were ~₹1,684 Cr, up ~12% YoY. The disproportionate jump in profit versus the modest topline is the whole story — this was margin, not volume-scale, driven. Adjusted for the ₹6.99 Cr exceptional loss in the year-ago base, PAT growth is ~+67%, still firmly strong. Standalone PAT was ₹226.0 Cr (+69% YoY, EPS ₹16.88); the ₹7.2 Cr joint-venture profit share (vs ₹0.8 Cr a year ago) lifts the consolidated figure a touch higher, so the two bases tell the same premiumisation story.
Q1 FY-2027 vs prior quarters
The margin bridge is the key: estimated EBITDA rose to ~₹349 Cr from ~₹232 Cr, taking the EBITDA margin on net sales to roughly 20.7% from ~15.4% a year ago — a >500 bps expansion that already dwarfs management's full-year guidance of ~125 bps. Net profit margin on gross revenue expanded to 3.9% from 2.5% YoY (3.5% last quarter). The lift is consistent with the company's premium-led mix shift; Magic Moments Vodka alone clocked 3.25 million cases in the quarter, and the Prestige-&-Above/luxury push is where the operating leverage is showing up. Finance costs eased to ₹11.7 Cr from ₹15.9 Cr YoY, aiding the print and consistent with the stated goal of turning debt-free in H1 FY27.
The stock went into the print at ₹4,162.2, up 7.4% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.
Management provides a strong outlook for FY27, guiding for 20% volume growth in its Prestige & Above portfolio and 25% value growth in its luxury segment. They project a full-year EBITDA margin expansion of 125 basis points, driven by premiumisation, operating leverage, and price increases, while also anticipating 3-5%
— This quarter: met
Against the Street, this is a beat on profitability: Equirus had modelled PAT of ~₹209 Cr and an EBITDA margin of ~19.1%; actual PAT of ₹230 Cr and a ~20.7% margin came in ahead, even as net sales (~₹1,684 Cr) landed a shade below the ₹1,731 Cr estimate. So the quarter confirms — and runs ahead of — the bullish, confident tone management struck on the Q4 concall, when it guided 20% Prestige-&-Above volume growth and 125 bps of FY27 margin expansion. The board approved the unaudited results today (July 28); the 42nd AGM is set for August 7 with the FY26 dividend on the docket. The QoQ optics (PAT +28%, revenue +13%) partly reflect the seasonally softer March quarter and are supporting detail, not the headline — the YoY margin story is what matters.
W1
Whether the ~20.7% EBITDA margin holds through FY27 against the guided ~125 bps expansion — Q1 is already well ahead
W2
Delivery on 20% Prestige-&-Above volume growth and 25% luxury value growth guidance in coming quarters
W3
Confirmation of debt-free status in H1 FY27; finance costs already easing (₹11.7 Cr this quarter)
Source in ₹ Lakhs, converted to ₹ Cr (÷100). Revenue from operations is gross (includes ₹4,184 Cr excise duty); net sales ex-excise ≈₹1,684 Cr. Consol PBT adds JV profit share ₹7.17 Cr (vs ₹0.77 Cr YoY). No exceptional item this quarter; year-ago Q1FY26 carried a ₹6.99 Cr exceptional loss (adjust base). Tax = current ₹78.16 Cr + deferred credit ₹2.78 Cr.
Informational and educational content only. Not investment advice.